This page is an outline of the most recent research news direct from the Horizon 2020 website. This webpage provides you with direct access to the Horizon 2020 RSS Feed (http://ec.europa.eu/programmes/horizon2020/rss.xml)Please Note: The information on this page is download directly and automatically from the Horizon 2020 RSS feeds at http://ec.europa.eu. The EPA have no control over the currency or content of these RSS feeds. They are supplied for information purposes only. Please check http://ec.europa.eu/programmes/horizon2020/ for the most up-to-date information on Horizon 2020 funding and related activities.
The FET-Open CSA project FET2RIN’s main goal is helping researchers to learn how to rapidly develop and test novel solutions by gathering feedback. Many projects fail to generate impact, as startups fail to succeed on the market, by not validating their ideas early on, with real-life customers. To mitigate that, researchers attending FET2RIN workshops will learn how to apply the lean start-up approach, getting out of the lab, search for unmet needs and validate their impact related assumptions.
FET2Rin coaches will guide FET teams through assumption identification, customer interviews, rapid experimentation, and new exploitation opportunities. FET2RIN training pushes teams outside their comfort zone and changes the way they look at research results in the view of use and impact.
The 4th edition of FET2Rin training will be held from mid-Mach to mid-May 2018, consisting of both online and on-site in Brussels sessions. If you are interested to know more or you want to apply for the training, please visit the FET2Rin website.
CellViewer consortium will develop a unique cutting-edge high-throughput super-resolution (SR) microscopy approach (including new hardware and software development) to collect a large amount of spatial and dynamic information in single cells. CellViewer technologies will allow studying the mechanisms of mouse embryonic stem cell (mESC) self-renewal and differentiation upon application of specific stimuli, as a specific test case.
In addition to its high impact on stem cell characterization, tissue engineering and regeneration, CellViewer will contribute further to the optimization of personalized medicine as it can be adapted to characterize a group of genes and gene products in a wild type or tumour biopsy cells from patients.
The CURE project proposes to do exactly that. In a previously EU funded project (PREDICTA) researchers from the Universities of Manchester and Athens have detected a correlation in the population changes of the bacteria and the bacterial viruses (phages) of the airways of asthmatic patients, including children. Building on this result, the CURE project proposes to test whether a new radical approach, phage therapy, could be effective in rebalancing the bacterial population of the airways, a possible underlying cause of asthma. The project will investigate how phage addition impacts the ecology of the airways and will design appropriate interventions for further use in clinical trials.
The CURE project gathers multidisciplinary expertise committed to develop new knowledge and work closely with relevant stakeholders towards a cure for asthma. The European Federation of Allergy and Airways Disease Patients' Associations (EFA) is one of the partners. The project is coordinated by the University of Athens (NKUA). If you are curious to know more about this FET-Open project's consortium, objectives and achievement, please visit CURE website.
This page has been printed from DROPLET which has been developed and hosted by the Environmental Protection Agency.
The URL of this page is http://erc.epa.ie/droplet/funding2.php